Table 2.

Plasma measurements (n=16, i.e. all patients included).

Molecule	Aneurysm Lumen (pg/ml)	Femoral Artery (pg/ml)	P value
RANTES	610.7±224.7	415.5±154.9	0.03
MIG	136.2±95.1	45.1±65.2	0.0005
IP-10	24.4±13.6	16.2±7.8	0.002
Eotaxin	43±23.8	35.0±12.7	0.04
IL8	23.4±3.7	21.4±3.1	0.04
IL17	41.8±3.0	39.6±2.8	0.02
IL1-beta	15.2±3.9	15.5±4.3	0.6
IL1 Receptor Antagonist	111.1±28.9	105.5±25.2	0.3
IL2	28.7±3.1	29.9±5.9	0.3
IL2 Receptor	87.0±46.2	86.9±43.7	0.6
IL4	93.9±13.5	92.7±17.5	0.6
IL5	7.7±2.2	7.5±2.1	0.4
IL6	7.6±2.9	8.8±3.6	0.04
IL7	15.0±3.0	15.7±3.6	0.4
IL10	38.2±5.8	39.7±8.4	0.3
IL12	95.2±28	97.5±34.3	0.6
IL13	31.8±2.6	31.3±2.6	0.6
IL15	67.6±12.2	63.2±12.2	0.1
Vascular Endothelial Growth Factor	1.1±0.3	0.9±0.2	0.2
Granulocyte Colony Stimulating Factor	12.9±6.9	10.9±2.7	0.4
Epidermal Growth Factor	15.5±3.9	15.6±4.6	0.7
Basic Fibroblast Growth Factor	8.8±3.9	10.2±5.5	0.09
Granulocyte Monocyte Colony Stimulating Factor	27.8±2.9	28.0±3.8	0.2
Tumor Necrosis Factor-alpha	16.4±1.3	16.0±1.6	0.5
Interferon-alpha	43.3±11.7	37.2±8.9	0.08
Interferon-Gamma	23.3±1.8	23.1±2.6	0.9
Macrophage inflammatory protein-1-alpha	28.3±2.3	28.2±3.5	0.9
Macrophage Inflammatory Protein-1-beta	38.3±30.9	38.8±31.1	0.7
MCP-1	154.8±69.4	148.7±69.5	0.7